Morgan Stanley (NYSE:MS) Given Consensus Recommendation of “Hold” by Brokerages

Shares of Morgan Stanley (NYSE:MSGet Free Report) have been given a consensus recommendation of “Hold” by the twenty research firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, twelve have given a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued a report on the stock in the last year is $101.45.

MS has been the topic of a number of research analyst reports. Wells Fargo & Company downgraded shares of Morgan Stanley from an “equal weight” rating to an “underweight” rating and reduced their price target for the company from $99.00 to $95.00 in a research note on Friday, August 2nd. Royal Bank of Canada boosted their price target on shares of Morgan Stanley from $91.00 to $108.00 and gave the company a “sector perform” rating in a research note on Wednesday, July 17th. Citigroup upped their target price on shares of Morgan Stanley from $98.00 to $105.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 17th. UBS Group upped their target price on shares of Morgan Stanley from $100.00 to $105.00 and gave the stock a “neutral” rating in a research note on Tuesday, July 9th. Finally, JMP Securities reaffirmed a “market perform” rating on shares of Morgan Stanley in a research note on Thursday, July 18th.

Get Our Latest Analysis on MS

Morgan Stanley Price Performance

Morgan Stanley stock opened at $102.63 on Friday. The company’s 50 day simple moving average is $100.25 and its 200-day simple moving average is $95.18. The company has a market capitalization of $166.79 billion, a price-to-earnings ratio of 18.69, a price-to-earnings-growth ratio of 1.05 and a beta of 1.38. Morgan Stanley has a 1 year low of $69.42 and a 1 year high of $109.11. The company has a debt-to-equity ratio of 2.97, a quick ratio of 0.77 and a current ratio of 0.77.

Morgan Stanley (NYSE:MSGet Free Report) last released its quarterly earnings results on Tuesday, July 16th. The financial services provider reported $1.82 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.65 by $0.17. The business had revenue of $15.02 billion for the quarter, compared to the consensus estimate of $14.32 billion. Morgan Stanley had a net margin of 10.17% and a return on equity of 11.90%. The business’s revenue was up 11.6% on a year-over-year basis. During the same period in the previous year, the firm earned $1.24 EPS. As a group, equities research analysts expect that Morgan Stanley will post 7 earnings per share for the current year.

Morgan Stanley Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Wednesday, July 31st were issued a $0.925 dividend. This is a boost from Morgan Stanley’s previous quarterly dividend of $0.85. The ex-dividend date was Wednesday, July 31st. This represents a $3.70 annualized dividend and a dividend yield of 3.61%. Morgan Stanley’s dividend payout ratio is presently 67.40%.

Insider Activity

In other news, Chairman James P. Gorman sold 200,000 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $105.06, for a total value of $21,012,000.00. Following the completion of the transaction, the chairman now owns 150,000 shares in the company, valued at approximately $15,759,000. The sale was disclosed in a document filed with the SEC, which is available at this link. In related news, insider Daniel A. Simkowitz sold 40,000 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $106.54, for a total value of $4,261,600.00. Following the completion of the sale, the insider now owns 442,522 shares in the company, valued at approximately $47,146,293.88. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Chairman James P. Gorman sold 200,000 shares of the company’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $105.06, for a total transaction of $21,012,000.00. Following the completion of the sale, the chairman now owns 150,000 shares of the company’s stock, valued at approximately $15,759,000. The disclosure for this sale can be found here. In the last quarter, insiders sold 252,000 shares of company stock worth $26,546,370. Corporate insiders own 0.24% of the company’s stock.

Hedge Funds Weigh In On Morgan Stanley

Large investors have recently bought and sold shares of the company. Opal Wealth Advisors LLC purchased a new position in Morgan Stanley during the 2nd quarter worth $25,000. POM Investment Strategies LLC raised its position in Morgan Stanley by 1,147.6% during the 2nd quarter. POM Investment Strategies LLC now owns 262 shares of the financial services provider’s stock worth $25,000 after buying an additional 241 shares during the last quarter. Bank & Trust Co purchased a new position in Morgan Stanley during the 2nd quarter worth $26,000. University of Texas Texas AM Investment Managment Co. purchased a new position in Morgan Stanley during the 4th quarter worth $25,000. Finally, Bbjs Financial Advisors LLC purchased a new position in Morgan Stanley during the 2nd quarter worth $29,000. Hedge funds and other institutional investors own 84.19% of the company’s stock.

About Morgan Stanley

(Get Free Report

Morgan Stanley, a financial holding company, provides various financial products and services to corporations, governments, financial institutions, and individuals in the Americas, Europe, the Middle East, Africa, and Asia. It operates through Institutional Securities, Wealth Management, and Investment Management segments.

Featured Stories

Analyst Recommendations for Morgan Stanley (NYSE:MS)

Receive News & Ratings for Morgan Stanley Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morgan Stanley and related companies with MarketBeat.com's FREE daily email newsletter.